Abstract
Infliximab is a human-murine chimeric monoclonal antibody directed against tumor necrosis factor α (TNFα). Infliximab and other TNF blockers are used to treat inflammatory diseases such as rheumatoid arthritis (RA). TNF blockers are suspected to play a key role in some infections. We report here two cases of Listeria monocytogenes sepsis associated with infliximab treatment for RA. The first patient developed a terminal ileitis and a bacteraemia after three doses of infliximab; the second RA patient presented a bacteraemia associated with a prosthetic joint arthritis of the left hip, both related to Listeria. Those two cases occurred in a population of 518 patients treated with TNF blockers in our hospitals since the year 2000. Those events are of particular interest because of the severity of the infection, because the treatment differs from other infections, and because that, in the rheumatology unit, septic arthritis can mimic RA symptoms. They enhance the likelihood for this drug to increase the risk for infections with germs like Listeria.
This is a preview of subscription content, log in via an institution to check access.
References
Slifman NR, Gershon SK, Lee JH et al (2003) Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum 48:319–324
Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098–1104
Gomez-Reino JJ, Carmona L, Valverde VR et al (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48:2122–2127
Durez P, Vander Cruyssen B, Westhovens R et al (2006) Four-years effects of infliximab utilisation in a large multicentric Belgian cohort of patients presenting refractory rheumatoid arthritis. Ann Rheum Dis 65(Suppl II):349
Schett G, Herak P, Graninger W et al (2005) Listeria-associated arthritis in a patient undergoing etanercept therapy: case report and review of the literature. J Clin Microbiol 43:2537–2541
Kroesen S, Widmer AF, Tyndall A et al (2003) Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology (Oxford) 42:617–621
Tweezer-Zaks N, Shiloach E, Spivak A et al (2003) Listeria monocytogenes sepsis in patients treated with anti-tumor necrosis factor-alpha. Isr Med Assoc J 5:829–830
Ooi ST, Lorber B (2005) Gastroenteritis due to Listeria monocytogenes. Clin Infect Dis 40:1327–1332
Cone LA, Fitzmorris AO, Hirschberg JM (2001) Is Listeria monocytogenes an important pathogen for prosthetic joints? J Clin Rheumatol 7:34–37
Chougle A, Narayanaswamy V (2004) Delayed presentation of prosthetic joint infection due to Listeria monocytogenes. Int J Clin Pract 58:420–421
Kabel PJ, Lorie CA, Vos MC et al (1995) Prosthetic hip-joint infection due to Listeria monocytogenes. Clin Infect Dis 20:1080–1081
Tabib W, Guiffault P, Lemort CB et al (2002) Prosthetic hip joint infection caused by Listeria monocytogenes. Acta Orthop Belg 68:182–186
Cornelius LK, Reddix RN Jr, Carpenter JL (2003) Periprosthetic knee joint infection following colonoscopy. A case report. J Bone Joint Surg Am 85:2434–2436
Anguita-Alonso P, Hanssen AD, Patel R (2005) Prosthetic joint infection. Expert Rev Anti Infect Ther 3:797–804
Marculescu CE, Berbari EF, Hanssen AD et al (2006) Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 42:471–478
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kesteman, T., Yombi, JC., Gigi, J. et al. Listeria infections associated with infliximab: case reports. Clin Rheumatol 26, 2173–2175 (2007). https://doi.org/10.1007/s10067-007-0660-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0660-8